Mubasher TV
Contact Us Advertising   العربية

Alexandria Pharmaceuticals’ profit grows 23% in Q1-19/20 unaudited financials

Alexandria Pharmaceuticals’ profit grows 23% in Q1-19/20 unaudited financials
The company’s revenues increased to EGP 255.9 million
Alexandria Pharmaceuticals
AXPH
-9.52% 210.01 -22.09

Cairo – Mubasher: The unaudited financial results of Alexandria Pharmaceuticals and Chemical Industries showed a 22.85% year-on-year profit rise during the first quarter of fiscal year 2019/2020.

Net profits grew to EGP 37.87 million in the three-month period ended 30 September, compared to EGP 30.83 million in the prior-year period, the company said in a statement to the Egyptian Exchange (EGX) on Monday.

The company’s revenues increased to EGP 255.9 million in July-September period from EGP 215.4 million in the corresponding period a year earlier.

It is noteworthy that during FY18/19, the company’s profit retreated to EGP 112.8 million, compared to EGP 118.2 million in FY17/18.